BRBruna Amanda Cruz Rattis

Bruna Amanda Cruz Rattis

*This is an algorithmically generated author record based on publicly available information.

Bruna Amanda Cruz Rattis has a total of 58 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    A fungal-induced immune response that mediates resistance against COVID-19

    by Rafaela Lúcia Lopes de Souza, Luciana Benevides, Thaís da Silva Rigoni, Rodrigo Paolo Flores Abuna, Bruna Amanda da Cruz Rattis, Osvaldo Campos dos Santos Nonato, Anamélia Lorenzetti Bocca, Ricardo Tostes Gazzinelli, João Santana Silva

  • Open Access

    Modulation of the mTOR Pathway by Curcumin in the Heart of Septic Mice

    by Bruna A. C. Rattis, Henrique L. Piva, Andressa Duarte, Frederico G. F. L. R. Gomes, Janaína R. Lellis, Danilo F. Soave, Simone G. Ramos, Antonio C. Tedesco, Mara R. N. Celes

    MTOR is a signaling pathway involved in cell survival, cell stress response, and protein synthesis that may be a key point in sepsis-induced cardiac dysfunction. Curcumin has been reported in vitro as an mTOR inhibitor compound; however, there are no studies demonstrating this effect in experimental sepsis. Thus, this study aimed to evaluate the action of curcumin on the mTOR pathway in the heart of septic mice. Free curcumin (FC) and nanocurcumin (NC) were used, and samples were obtained at 24 and 120 h after sepsis. Histopathological and ultrastructural analysis showed that treatments with FC and NC reduced cardiac lesions caused by sepsis. Our main results demonstrated that curcumin reduced mTORC1 and Raptor mRNA at 24 and 120 h compared with the septic group; in contrast, mTORC2 mRNA increased at 24 h. Additionally, the total mTOR mRNA expression was reduced at 24 h compared with the septic group. Our results indicate that treatment with curcumin and nanocurcumin promoted a cardioprotective response that could be related to the modulation of the mTOR pathway.


  • Open Access

    Impact of Microbiota Depletion by Antibiotics on SARS-CoV-2 Infection of K18-hACE2 Mice

    by Patrícia Brito Rodrigues, Giovanni Freitas Gomes, Monara K. S. C. Angelim, Gabriela F. Souza, Stefanie Primon Muraro, Daniel A. Toledo-Teixeira, Bruna Amanda Cruz Rattis, Amanda Stephane Passos, Laís Passarielo Pral, Vinícius de Rezende Rodovalho, et al.

    Clinical and experimental data indicate that severe acute respiratory syndrome coronavirus (SARS-CoV)-2 infection is associated with significant changes in the composition and function of intestinal microbiota. However, the relevance of these effects for SARS-CoV-2 pathophysiology is unknown. In this study, we analyzed the impact of microbiota depletion after antibiotic treatment on the clinical and immunological responses of K18-hACE2 mice to SARS-CoV-2 infection. Mice were treated with a combination of antibiotics (kanamycin, gentamicin, metronidazole, vancomycin, and colistin, Abx) for 3 days, and 24 h later, they were infected with SARS-CoV-2 B lineage. Here, we show that more than 80% of mice succumbed to infection by day 11 post-infection. Treatment with Abx had no impact on mortality. However, Abx-treated mice presented better clinical symptoms, with similar weight loss between infected–treated and non-treated groups. We observed no differences in lung and colon histopathological scores or lung, colon, heart, brain and kidney viral load between groups on day 5 of infection. Despite some minor differences in the expression of antiviral and inflammatory markers in the lungs and colon, no robust change was observed in Abx-treated mice. Together, these findings indicate that microbiota depletion has no impact on SARS-CoV-2 infection in mice.


  • Open Access

    Protective Immunity against Gamma and Zeta Variants after Inactivated SARS-CoV-2 Virus Immunization

    by Marcilio Jorge Fumagalli, Luiza Antunes Castro-Jorge, Thais Fernanda de Campos Fraga-Silva, Patrick Orestes de Azevedo, Carlos Fabiano Capato, Bruna Amanda Cruz Rattis, Natália Satchiko Hojo-Souza, Vitor Gonçalves Floriano, Julia Teixeira de Castro, Simone Gusmão Ramos, et al.

    The persistent circulation of SARS-CoV-2 represents an ongoing global threat due to the emergence of new viral variants that can sometimes evade the immune system of previously exposed or vaccinated individuals. We conducted a follow-up study of adult individuals that had received an inactivated SARS-CoV-2 vaccine, evaluating antibody production and neutralizing activity over a period of 6 months. In addition, we performed mice immunization with inactivated SARS-CoV-2, and evaluated the immune response and pathological outcomes against Gamma and Zeta variant infection. Vaccinated individuals produced high levels of antibodies with robust neutralizing activity, which was significantly reduced against Gamma and Zeta variants. Production of IgG anti-S antibodies and neutralizing activity robustly reduced after 6 months of vaccination. Immunized mice demonstrated cellular response against Gamma and Zeta variants, and after viral infection, reduced viral loads, IL-6 expression, and histopathological outcome in the lungs. TNF levels were unchanged in immunized or not immunized mice after infection with the Gamma variant. Furthermore, serum neutralization activity rapidly increases after infection with the Gamma and Zeta variants. Our data suggest that immunization with inactivated WT SARS-CoV-2 induces a promptly responsive cross-reactive immunity response against the Gamma and Zeta variants, reducing COVID-19 pathological outcomes.


  • Open Access

    Why Should Clinical Autopsies Continue to Exist?

    by Simone Gusmão Ramos, Giulia Ottaviani, Luiz Cesar Peres, Bruna Amanda Cruz Rattis, Patricia Santos Leão, Thamiris Nadaf Akel, Leticia Ussem, Caio Antonio Campos Prado, Elaine Christine Dantas Moises, Lilian Christiane Andrade Grimm, et al.

    At some point in history, medicine was integrated with pathology, more precisely, with pathological anatomy